Shenzhen Sijia Pharmaceutical provides one-stop sourcing for global pharmaceutical manufacturers, supplying active pharmaceutical substances, advanced intermediates, excipients, and reference standards for specialty and generic drugs — including sugammadex sodium, ruxolitinib phosphate, roxadustat, osimertinib mesylate, micafungin sodium, lenalidomide, and delafloxacin meglumine — alongside regulatory support such as DMF filings in CTD format and cGMP audit services spanning R&D through commercial production. Offering ODM development and CRO services, the company accepts buyer-specified requirements and small orders, serving markets across North America, Europe, Asia, the Middle East, Africa, and Australasia.
No comments available.
Leave your rating & comment